Pros and cons of sharing Zika discoveries straight from the lab

The quick spread and potentially devastating public health risks of the Zika virus in North and South America have researchers, drug companies and government officials scrambling to land on a plan to fight back.

But considering the magnitude of these endeavors, the efforts are so many and so widespread that data sharing might not be as efficient as necessary to develop a cure or vaccine as soon as possible.

So, according to the New York Times, one research team at the University of Wisconsin in Madison is giving away its Zika information for free online. The data is available for other scientists and physicians to build upon the existing research, for faster and cheaper advancements.

Of course, this also means that the researchers forgo the prestige and some of the peer-reviewed legitimacy that comes with being published in a journal.

Check out the New York Times to see how the researchers use monkeys to conduct their research along with the reaction from the rest of the scientific community. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup